Anonymous sources
FiercePharma
Sources: Valeant eyes Meda for potential $4.4B deal - FiercePharma
The Canadian drugmaker has approached Swedish specialty pharma Meda about a deal, sources close to the companies are saying. With a current market value of about $3.4 billion, Meda could fetch up to $4.4 billion with a typical premium of 30%, ...
Reports: AZ close to selling dental unit to Dentsply - FiercePharma
A number of sources are reporting this morning that AstraZeneca is close to an agreement for selling its dental implant and medical device unit Astra Tech to Dentsply International for approximately $1.8 billion, said a person close to the deal. ...
CVRs make Genzyme a bargain, Bloomberg says - FiercePharma
As the week comes to a close, and sources close to the Genzyme/Sanofi-Aventis deal predict success as soon as Monday, Bloomberg assesses the leaked ...
Citigroup begins auction of Biofarma; Cephalon's Baldino won't be back in 2010 ; - FiercePharma
Citigroup's venture capital arm and two co-investors have begun an auction of Turkish copycat drugmaker Biofarma, three people familiar with the matter said ...